SCHEDULE OF WARRANTS OUTSTANDING (Details) $ / shares in Units, $ in Thousands |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
USD ($)
$ / shares
shares
| |
| Stock Warrants | |
| Number of Shares, Warrants Outstanding Beginning | shares | 1,681,392 |
| Weighted-Average Exercise Price, Outstanding Beginning | $ / shares | $ 3.23 |
| Aggregate Intrinsic Value Outstanding Beginning | $ | $ 3,339 |
| Number of Shares, Warrants granted | shares | |
| Weighted-Average Exercise Price, granted | $ / shares | |
| Number of Shares, Warrants forfeited | shares | |
| Weighted-Average Exercise Price, forfeited | $ / shares | |
| Number of Shares, Warrants exercised | shares | |
| Weighted-Average Exercise Price, exercised | $ / shares | |
| Number of Shares, Warrants Outstanding Ending | shares | 1,681,392 |
| Weighted-Average Exercise Price, Outstanding Ending | $ / shares | $ 3.23 |
| Aggregate Intrinsic Value Outstanding Ending | $ | $ 4,144 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when warrants forfeited. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|